Dmowski W Paul, Pry Michelle, Ding Jianchi, Rana Nasir
Institute for the Study and Treatment of Endometriosis, Oak Brook, Illinois, USA.
Fertil Steril. 2002 Oct;78(4):750-6. doi: 10.1016/s0015-0282(02)03343-5.
To compare controlled ovarian hyperstimulation-intrauterine insemination (COH-IUI) or IVF-ET pregnancy rates per cycle (PR) and cycle and cumulative fecundity (f and cf) with COH-IUI or IVF-ET in endometriosis.
Retrospective analysis.
Endometriosis research institute.
PATIENT(S): Women with endometriosis and infertility (n = 313) who underwent consecutive COH-IUI (202 patients, 648 cycles), IVF-ET (111 patients, 139 cycles), or IVF-ET after failed COH-IUI (56 patients, 68 cycles).
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Crude PR and life table-estimated f and cf.
RESULT(S): With COH-IUI, 69 patients conceived; 65 conceived with IVF-ET; and 30 conceived with IVF-ET after COH-IUI (PR 11%, 47%, and 44%). With COH-IUI, six-cycle cf was 41%, and f for cycles 1-6 was 15%, 12%, 8%, 7%, 7%, and 0. With IVF-ET, three-cycle cf was 73%, whereas f for cycles 1-3 was 47%, 27%, and 33%. First-cycle f with IVF-ET was significantly higher than cf of six COH-IUI cycles. When the data were stratified according to the stage of endometriosis and women's age, the benefit of IVF over COH was even more pronounced. Prior COH-IUI failure did not adversely affect IVF-ET outcome.
CONCLUSION(S): In endometriosis, PR, f, and cf are significantly higher with IVF-ET than COH-IUI, especially in stage IV and in women >38 years of age. Considering adverse effects of prolonged ovarian stimulation on endometriosis, IVF-ET should be the first-line approach in the management of infertility in this disease. If COH-IUI is attempted, it should not exceed three to four cycles.
比较在子宫内膜异位症患者中,控制性卵巢刺激-宫腔内人工授精(COH-IUI)或体外受精-胚胎移植(IVF-ET)每个周期的妊娠率(PR)、周期生育力及累积生育力(f和cf)。
回顾性分析。
子宫内膜异位症研究所。
患有子宫内膜异位症和不孕症的女性(n = 313),她们连续接受了COH-IUI(202例患者,648个周期)、IVF-ET(111例患者,139个周期)或COH-IUI失败后接受IVF-ET(56例患者,68个周期)。
无。
粗妊娠率以及生命表估计的生育力和累积生育力。
接受COH-IUI的患者中,69例受孕;接受IVF-ET的患者中,65例受孕;COH-IUI失败后接受IVF-ET的患者中,30例受孕(PR分别为11%、47%和44%)。接受COH-IUI的患者,六个周期的累积生育力为41%,第1至6个周期的生育力分别为15%、12%、8%、7%、7%和0。接受IVF-ET的患者,三个周期的累积生育力为73%,第1至3个周期的生育力分别为47%、27%和33%。IVF-ET第一个周期的生育力显著高于COH-IUI六个周期的累积生育力。根据子宫内膜异位症分期和女性年龄对数据进行分层时,IVF相对于COH的优势更加明显。先前COH-IUI失败并未对IVF-ET结局产生不利影响。
在子宫内膜异位症患者中,IVF-ET的PR、生育力和累积生育力显著高于COH-IUI,尤其是在IV期患者和年龄大于38岁的女性中。考虑到长期卵巢刺激对子宫内膜异位症的不良影响,IVF-ET应作为该疾病不孕症治疗的一线方法。如果尝试COH-IUI,不应超过三到四个周期。